Ascendis Pharma A/SASNDNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+6.2%
5Y CAGR+16.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+6.2%/yr
vs +38.1%/yr prior
5Y CAGR
+16.3%/yr
Recent deceleration
Acceleration
-31.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.1x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $719.42M | +20.3% |
| 2024 | $598.15M | -11.8% |
| 2023 | $677.86M | +12.8% |
| 2022 | $600.85M | +31.8% |
| 2021 | $456.05M | +35.1% |
| 2020 | $337.57M | +40.6% |
| 2019 | $240.09M | +45.2% |
| 2018 | $165.34M | +46.2% |
| 2017 | $113.07M | +45.8% |
| 2016 | $77.53M | - |